PETNET Radiopharmacy acquired by Siemens MedicalAlong with its subsidiary PETNET Pharmaceuticals Inc (Knoxville, Tenn), Siemens Medical Solutions (Malvern, Pa) has acquired full ownership of New England PETNET Manufacturing & Distribution Center LLC (Woburn, Mass). The acquisition, a result of continuing expansion efforts, enables Siemens Medical and PETNET to provide biomarkers for clinical and preclinical PET imaging to the New England region through PETNET's SafetyNet international network of more than 45 manufacturing and distribution centers.
PETNET, Siemens' distribution channel for biomarkers, is a leading producer and distributor of PET biomarkers, with a large US network of cyclotron-equipped radiopharmacies. "In addition to biomarker delivery and solutions for the research and clinical markets, PETNET customers in the New England region will have access to an array of programs to support and enable the continuous development of their skills, productivity, and technology," said Michael Reitermann, president of the molecular imaging division at Siemens Medical. "We offer a full spectrum of educational and marketing modules to help our customers develop and grow their practices, as well as gain greater awareness of payor positions on reimbursement."
Molecular imaging biomarkers enable the biological mechanisms of disease to be identified and understood. Results could help physicians determine personalized therapies for patients by pinpointing the active pathways in the disease's progression. "As the technologies evolve, PETNET offers advanced products and services that optimize diagnostic accuracy and help support business growth," Reitermann added.
Want more information about molecular imaging and its future? Don't miss "Mapping Improvements in Molecular Imaging," our cover story.
|